E-resources
Open access
-
Lutrick, Karen; Fowlkes, Ashley; Rivers, Patrick; Herder, Katherine; Santibanez, Tammy A; LeClair, Lindsay; Groover, Kimberly; Lamberte, Julie Mayo; Grant, Lauren; Odame-Bamfo, Leah; Ferraris, Maria V; Phillips, Andrew L; Sokol, Brian; Lowe, Ashley A; Mathenge, Clare; Pubillones, Felipe A; Cottam, Brianna; McLeland-Wieser, Hilary; Jovel, Krystal S; Ochoa, Jezahel S; Mckell, Jacob; Berry, Mark; Khan, Sana; Solle, Natasha Schaefer; Rai, Ramona P; Nakayima, Flavia Miiro; Newes-Adeyi, Gabriella; Porter, Cynthia; Baccam, Zoe; Ellingson, Katherine D; Burgess, Jeffery L; Gaglani, Manjusha; Gwynn, Lisa; Caban-Martinez, Alberto; Yoon, Sarang
MMWR. Morbidity and mortality weekly report, 09/2022, Volume: 71, Issue: 35Journal Article, Newsletter
What is already known on this topic? In June 2022, COVID-19 vaccines were authorized for use in children aged 6 months–5 years. Intent to vaccinate and vaccination rates in children have been low. What is added by this report? During July 2021–May 2022, in a longitudinal cohort of 393 children aged <5 years in four states, parental intent to vaccinate children against COVID-19 and perception of COVID-19 vaccine safety and effectiveness declined over a 3-month period, but intent to vaccinate and perceptions of vaccine safety returned to baseline after 6 months. What are the implications for public health practice? Identifying and addressing barriers to COVID-19 vaccination in children aged <5 years and educating parents about COVID-19 vaccine effectiveness and safety in young children are critical to increasing pediatric COVID-19 vaccination coverage.
